HeartSciences Inc.
NCM: HSCSLive Quote
📈 ZcoreAI Score
Our AI model analyzes HeartSciences Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get HSCS Z-Score →About HeartSciences Inc.
Healthcare
Medical Devices
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
📊 Fundamental Analysis
HeartSciences Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -382.3%, which indicates that capital utilization is currently under pressure.
At a current price of $2.08, HSCS currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $2.01 - $6.47).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$6.62M
Trailing P/E
--
Forward P/E
-0.74
Beta (5Y)
2.45
52W High
$6.47
52W Low
$2.01
Avg Volume
17K
Day High
Day Low